A combined biomarker panel shows improved sensitivity for the early detection of ovarian cancer allowing the identification of the most aggressive type II tumours. (2017)
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1038/bjc.2017.199
PubMed Identifier: 28664912
Publication URI: http://europepmc.org/abstract/MED/28664912
Type: Journal Article/Review
Volume: 117
Parent Publication: British journal of cancer
Issue: 5
ISSN: 0007-0920